cefoperazone has been researched along with mezlocillin in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (76.19) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 2 (9.52) | 29.6817 |
| 2010's | 1 (4.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
| Atabey, N; Gökoğlu, M | 1 |
| Acar, JF; Denis, F; Drugeon, H; Fleurette, J; Kazmierczak, A; Siebor, E; Sirot, J; Soussy, CJ; Thabaut, A | 1 |
| Cohen, MS; Faubion, C; Gordon, LI; McMahan, R; Murphy, RL; Pegram, PS; Phair, JP; Saviteer, S; Washton, H | 1 |
| Cesari, C; Cimino, M; Fenner, J; Rotstein, C; Winkey, K | 1 |
| Blacklock, H; Corringham, R; Devereux, S; Guimaraes, M; Hann, I; Hoffbrand, AV; Prentice, HG; Sage, R; Stirling, L; Trikka, E | 1 |
| Alivisatos, MR; Bollinger, MR; Greenberg, RN | 1 |
| Black, D; Kirby, WM; Kwok, K; Miller, S; Mortimer, J | 1 |
| Bodey, GP; Fainstein, V; Jones, P; Riccardi, S; Rolston, K | 1 |
| Bodey, GP; Fainstein, V; Jones, PG; Rolston, KV; Strother, SV | 1 |
| Adams, CR; Anderson, EL; Robinson, PA; Tu, KK | 1 |
| Arione, R; Bramato, C; Capra, E; Chiavarino, M; Cimino, T; Di Nola, F; Eandi, M; Grosa, M; Salassa, B; Soranzo, ML | 1 |
| Klastersky, J; Moody, M; Schimpff, SC; Standiford, HC; Tatem, B; Viollier, AF | 1 |
| Baker, CN; Jones, RN; Thornsberry, C | 1 |
| LeFrock, JL; Miller, MA; Vercler, MJ | 1 |
| Weinstein, AJ | 1 |
| Labthavikul, P; Neu, HC | 1 |
| Monteil, H; Peladan, F; Zinsius, M | 1 |
| Calderwood, SB; Jackson, E; Tung, CC | 1 |
7 trial(s) available for cefoperazone and mezlocillin
| Article | Year |
|---|---|
[In vitro activity of beta-lactam antibiotics in combination with sulbactam against enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter. Results of a multicenter study].
Topics: Acinetobacter; Cefoperazone; Cefotaxime; Ceftazidime; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enterobacteriaceae; Humans; In Vitro Techniques; Mezlocillin; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Ticarcillin | 1991 |
Prospective comparative trial of short course (four day) and continuous tobramycin in combination with cefoperazone or mezlocillin in febrile, granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Bacterial Infections; Cefoperazone; Drug Therapy, Combination; Female; Fever; Humans; Leukocyte Count; Male; Mezlocillin; Middle Aged; Prospective Studies; Randomized Controlled Trials as Topic; Tobramycin | 1989 |
Cefoperazone plus piperacillin versus mezlocillin plus tobramycin as empiric therapy for febrile episodes in neutropenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Humans; Male; Mezlocillin; Middle Aged; Neutropenia; Piperacillin; Prospective Studies; Random Allocation; Tobramycin | 1988 |
A randomized trial of empirical antibiotic therapy with one of four beta-lactam antibiotics in combination with netilmicin in febrile neutropenic patients.
Topics: Agranulocytosis; Anti-Bacterial Agents; Cefoperazone; Clinical Trials as Topic; Drug Therapy, Combination; Feces; Fever; Gram-Negative Bacteria; Humans; Mezlocillin; Microbial Sensitivity Tests; Netilmicin; Neutropenia; Piperacillin; Random Allocation; Respiratory System; Superinfection; Ticarcillin | 1988 |
Comparison of cefoperazone and mezlocillin with imipenem as empiric therapy in febrile neutropenic cancer patients.
Topics: Adult; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Mezlocillin; Neoplasms; Neutropenia; Thienamycins | 1988 |
Cefoperazone plus mezlocillin for empiric therapy of febrile cancer patients.
Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Cefoperazone; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Humans; Leukocyte Count; Male; Mezlocillin; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Neutrophils | 1988 |
Hypoprothrombinemia in patients with cancer receiving cefoperazone and mezlocillin.
Topics: Carotenoids; Cefoperazone; Clinical Trials as Topic; Creatinine; Drug Therapy, Combination; Factor VII; Humans; Hypoprothrombinemias; Mezlocillin; Neoplasms; Prealbumin; Prothrombin Time; Random Allocation; Time Factors | 1986 |
14 other study(ies) available for cefoperazone and mezlocillin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
[The effect of some antibiotics on primary antibody response].
Topics: Ampicillin; Animals; Antibody Formation; Cefoperazone; Drug Therapy, Combination; Mezlocillin; Rabbits; Rifamycins; Sulbactam | 1991 |
In vitro activity of piperacillin, ticarcillin, mezlocillin, ticarcillin-clavulanic acid, aztreonam, ceftazidime, azlocillin, cefoperazone, and thienamycin against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Azlocillin; Aztreonam; Cefoperazone; Ceftazidime; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Mezlocillin; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Ticarcillin | 1986 |
Beta-lactamase-positive strains of Haemophilus influenzae: susceptibility to and inactivation of beta-lactam antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefamandole; Cefoperazone; Cefotaxime; Ceftriaxone; Haemophilus influenzae; Mezlocillin; Microbial Sensitivity Tests; Moxalactam | 1985 |
[Cefoperazone: microbiological, kinetic and clinical studies].
Topics: Bacterial Infections; Bronchitis; Cefoperazone; Erysipelas; Humans; Kinetics; Mezlocillin; Piperacillin; Tonsillitis; Urinary Tract Infections | 1985 |
Antibiotic combinations against gram-negative bacilli and Staphylococcus aureus in cancer patients: comparative in-vitro and in-vivo activity of cefoperazone and mezlocillin singly or combined together.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefoperazone; Cephalosporins; Drug Therapy, Combination; Humans; Mezlocillin; Neoplasms; Penicillins; Staphylococcus aureus | 1982 |
In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains.
Topics: Azlocillin; beta-Lactamases; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Haemophilus influenzae; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Neisseria gonorrhoeae; Penicillin Resistance; Penicillins | 1980 |
Comparative activity of N-formimidoyl thienamycin with third generation cephalosporins and ureido penicillins against multiple resistant Serratia marcescens.
Topics: Azlocillin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Humans; Imipenem; Lactams; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Penicillins; Piperacillin; Serratia marcescens | 1981 |
The new cephalosporins and penicillins.
Topics: Azlocillin; Bacterial Infections; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Humans; Mezlocillin; Moxalactam; Penicillins; Piperacillin | 1982 |
Combination of mezlocillin and azlocillin with cephalosporin antibiotics: cefoxitin, cefoperazone, cefotaxime and moxalactam.
Topics: Anti-Bacterial Agents; Azlocillin; Bacteria; Cefoperazone; Cefotaxime; Cefoxitin; Cephalosporins; Cephamycins; Drug Synergism; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillins | 1982 |
[Comparative activity of azlocillin on Pseudomonas species excluding Pseudomonas aeruginosa].
Topics: Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefotaxime; Cefsulodin; Cephalosporins; Mezlocillin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas; Pseudomonas fluorescens | 1984 |
Measurement of levels of aminoglycosides and vancomycin in serum in the presence of new beta-lactam antibiotics.
Topics: Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefotaxime; Humans; Immunoenzyme Techniques; Mezlocillin; Moxalactam; Penicillins; Piperacillin; Vancomycin | 1984 |